These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 31744096)

  • 1. Reiber's Diagram for Kappa Free Light Chains: The New Standard for Assessing Intrathecal Synthesis?
    Schwenkenbecher P; Konen FF; Wurster U; Witte T; Gingele S; Sühs KW; Stangel M; Skripuletz T
    Diagnostics (Basel); 2019 Nov; 9(4):. PubMed ID: 31744096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kappa Free Light Chains in Cerebrospinal Fluid in Inflammatory and Non-Inflammatory Neurological Diseases.
    Konen FF; Schwenkenbecher P; Jendretzky KF; Gingele S; Witte T; Sühs KW; Grothe M; Hannich MJ; Süße M; Skripuletz T
    Brain Sci; 2022 Apr; 12(4):. PubMed ID: 35448006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Influence of Renal Function Impairment on Kappa Free Light Chains in Cerebrospinal Fluid.
    Konen FF; Schwenkenbecher P; Wurster U; Jendretzky KF; Möhn N; Gingele S; Sühs KW; Hannich MJ; Grothe M; Witte T; Stangel M; Süße M; Skripuletz T
    J Cent Nerv Syst Dis; 2021; 13():11795735211042166. PubMed ID: 34840504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Increasing Role of Kappa Free Light Chains in the Diagnosis of Multiple Sclerosis.
    Konen FF; Schwenkenbecher P; Jendretzky KF; Gingele S; Sühs KW; Tumani H; Süße M; Skripuletz T
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relevance of KFLC quantification to differentiate clinically isolated syndrome from multiple sclerosis at clinical onset.
    Vasilj M; Kes VB; Vrkic N; Vukasovic I
    Clin Neurol Neurosurg; 2018 Nov; 174():220-229. PubMed ID: 30278299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CSF Free Light Chains as a Marker of Intrathecal Immunoglobulin Synthesis in Multiple Sclerosis: A Blood-CSF Barrier Related Evaluation in a Large Cohort.
    Senel M; Mojib-Yezdani F; Braisch U; Bachhuber F; Lewerenz J; Ludolph AC; Otto M; Tumani H
    Front Immunol; 2019; 10():641. PubMed ID: 30984199
    [No Abstract]   [Full Text] [Related]  

  • 7. Kappa Free Light Chains in Cerebrospinal Fluid of Patients with Identified Oligoclonal Immunoglobulin G.
    Vasilj M; Klarić M; Vrkić N; Mikulić I; Boras MM; Jelić-Knezović N; Šoljić V
    Psychiatr Danub; 2017 May; 29(Suppl 2):124-128. PubMed ID: 28492219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of kappa free light chains as a diagnostic biomarker in multiple sclerosis and clinically isolated syndrome: A multicenter study.
    Presslauer S; Milosavljevic D; Huebl W; Aboulenein-Djamshidian F; Krugluger W; Deisenhammer F; Senel M; Tumani H; Hegen H
    Mult Scler; 2016 Apr; 22(4):502-10. PubMed ID: 26199348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Persisting Significance of Oligoclonal Bands in the Dawning Era of Kappa Free Light Chains for the Diagnosis of Multiple Sclerosis.
    Schwenkenbecher P; Konen FF; Wurster U; Jendretzky KF; Gingele S; Sühs KW; Pul R; Witte T; Stangel M; Skripuletz T
    Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30501024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid immunoglobulin kappa light chain in clinically isolated syndrome and multiple sclerosis.
    Senel M; Tumani H; Lauda F; Presslauer S; Mojib-Yezdani R; Otto M; Brettschneider J
    PLoS One; 2014; 9(4):e88680. PubMed ID: 24695382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrathecal kappa free light chains as markers for multiple sclerosis.
    Vecchio D; Bellomo G; Serino R; Virgilio E; Lamonaca M; Dianzani U; Cantello R; Comi C; Crespi I
    Sci Rep; 2020 Nov; 10(1):20329. PubMed ID: 33230241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of κ free light chains in cerebrospinal fluid as a biomarker in multiple sclerosis diagnosis: development of a diagnosis algorithm.
    Valencia-Vera E; Martinez-Escribano Garcia-Ripoll A; Enguix A; Abalos-Garcia C; Segovia-Cuevas MJ
    Clin Chem Lab Med; 2018 Mar; 56(4):609-613. PubMed ID: 29087953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High Levels of Cerebrospinal Fluid Kappa Free Light Chains Relate to IgM Intrathecal Synthesis and Might Have Prognostic Implications in Relapsing Multiple Sclerosis.
    Castillo-Villalba J; Gil-Perotín S; Gasque-Rubio R; Cubas-Nuñez L; Carratalà-Boscà S; Alcalá C; Quintanilla-Bordás C; Pérez-Miralles F; Ferrer C; Cañada Martínez A; Tortosa J; Solís-Tarazona L; Campos L; Leivas A; Laíz Marro B; Casanova B
    Front Immunol; 2022; 13():827738. PubMed ID: 35330910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kappa free light chains in cerebrospinal fluid to identify patients with oligoclonal bands.
    Süße M; Hannich M; Petersmann A; Zylla S; Pietzner M; Nauck M; Dressel A
    Eur J Neurol; 2018 Sep; 25(9):1134-1139. PubMed ID: 29683546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kappa free light chain index as a diagnostic biomarker in multiple sclerosis: A real-world investigation.
    Rosenstein I; Rasch S; Axelsson M; Novakova L; Blennow K; Zetterberg H; Lycke J
    J Neurochem; 2021 Nov; 159(3):618-628. PubMed ID: 34478561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic accuracy of intrathecal kappa free light chains compared with OCBs in MS.
    Duell F; Evertsson B; Al Nimer F; Sandin Å; Olsson D; Olsson T; Khademi M; Hietala MA; Piehl F; Hansson M
    Neurol Neuroimmunol Neuroinflamm; 2020 Jul; 7(4):. PubMed ID: 32527760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kappa Free Light Chain Biomarkers Are Efficient for the Diagnosis of Multiple Sclerosis: A Large Multicenter Cohort Study.
    Levraut M; Laurent-Chabalier S; Ayrignac X; Bigaut K; Rival M; Squalli S; Zéphir H; Alberto T; Pekar JD; Ciron J; Biotti D; Puissant-Lubrano B; Camdessanché JP; Tholance Y; Casez O; Toussaint B; Marion J; Moreau T; Lakomy D; Thomasset A; Maillart E; Sterlin D; Maurousset A; Rocher A; Laplaud DA; Bigot-Corbel E; Bertho PO; Pelletier J; Boucraut J; Labauge P; Vincent T; De Sèze J; Jahn I; Seitz-Polski B; Thouvenot E; Lebrun-Frenay C;
    Neurol Neuroimmunol Neuroinflamm; 2023 Jan; 10(1):. PubMed ID: 36376096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Updated Evaluation of Intrathecal IgG Synthesis Markers in Relation to Oligoclonal Bands.
    Boufidou F; Vakrakou AG; Anagnostouli M; Patas K; Paraskevas G; Chatzipanagiotou S; Stefanis L; Evangelopoulos ME
    Diagnostics (Basel); 2023 Jan; 13(3):. PubMed ID: 36766494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of Oligoclonal Bands Does Not Exclude Non-Inflammatory Neurological Diseases.
    Pannewitz-Makaj K; Wurster U; Jendretzky KF; Gingele S; Sühs KW; Stangel M; Skripuletz T; Schwenkenbecher P
    Diagnostics (Basel); 2020 Dec; 11(1):. PubMed ID: 33379245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intrathecal IgG synthesis: when is determination of oligoclonal bands necessary?].
    Kaiser R; Czygan M; Kaufmann R; Lücking CH
    Nervenarzt; 1995 Aug; 66(8):618-23. PubMed ID: 7566274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.